Literature DB >> 32593950

Examination of preliminary behavioral and effective connectivity findings from treatment response to citalopram in cocaine use disorder: A dynamic causal modeling study.

A D Snyder1, E Zuniga2, L Ma3, J L Steinberg4, K Woisard5, P A Narayana6, S Lane7, J Schmitz8, F G Moeller9.   

Abstract

We sought effective (directional) connectivity parameters associated with response to citalopram in cocaine use disorder (CUD) by conducting a functional magnetic resonance imaging (fMRI) experiment with participants diagnosed with CUD (n = 13) and matched healthy controls (HC; n = 17). CUD participants showed a positive correlation between bilateral DLPFC-to-putamen effective connectivity and treatment effectiveness score. These preliminary results support further investigation of prefrontal-striatal interactions in response to treatment in CUD.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Citalopram; Cocaine use disorder; Effective connectivity; Impulsivity; Selective serotonin reuptake inhibitor; Ssri

Mesh：

Substances：

Year:  2020        PMID： 32593950      PMCID： PMC8948471          DOI： 10.1016/j.pscychresns.2020.111127

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN： 0925-4927            Impact factor:   2.376


  10 in total

1.  Relationship between impulsivity and decision making in cocaine dependence.

Authors:  Kimberly L Kjome; Scott D Lane; Joy M Schmitz; Charles Green; Liangsuo Ma; Irshad Prasla; Alan C Swann; F Gerard Moeller
Journal:  Psychiatry Res       Date:  2010-05-15       Impact factor: 3.222

Review 2.  Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression.

Authors:  Collin Challis; Olivier Berton
Journal:  ACS Chem Neurosci       Date:  2015-03-17       Impact factor: 4.418

3.  Fronto-limbic effective connectivity as possible predictor of antidepressant response to SSRI administration.

Authors:  Benedetta Vai; Chiara Bulgarelli; Beata R Godlewska; Philip J Cowen; Francesco Benedetti; Catherine J Harmer
Journal:  Eur Neuropsychopharmacol       Date:  2016-10-15       Impact factor: 4.600

4.  Insensitivity to future consequences following damage to human prefrontal cortex.

Authors:  A Bechara; A R Damasio; H Damasio; S W Anderson
Journal:  Cognition       Date:  1994 Apr-Jun

5.  The role of serotonin in the neurocircuitry of negative affective bias: serotonergic modulation of the dorsal medial prefrontal-amygdala 'aversive amplification' circuit.

Authors:  Oliver J Robinson; Cassie Overstreet; Philip S Allen; Alison Letkiewicz; Katherine Vytal; Daniel S Pine; Christian Grillon
Journal:  Neuroimage       Date:  2013-04-11       Impact factor: 6.556

Review 6.  Neurocognitive mechanisms in depression: implications for treatment.

Authors:  Luke Clark; Samuel R Chamberlain; Barbara J Sahakian
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

7.  Evaluation of heterogeneity in pharmacotherapy trials for drug dependence: a Bayesian approach.

Authors:  C E Green; F G Moeller; J M Schmitz; J F Lucke; S D Lane; A C Swann; R E Lasky; J P Carbonari
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

8.  Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial.

Authors:  F Gerard Moeller; Joy M Schmitz; Joel L Steinberg; Charles M Green; Christopher Reist; Lingo Y Lai; Alan C Swann; John Grabowski
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

9.  Inhibitory behavioral control: A stochastic dynamic causal modeling study comparing cocaine dependent subjects and controls.

Authors:  Liangsuo Ma; Joel L Steinberg; Kathryn A Cunningham; Scott D Lane; James M Bjork; Harshini Neelakantan; Amanda E Price; Ponnada A Narayana; Thomas R Kosten; Antoine Bechara; F Gerard Moeller
Journal:  Neuroimage Clin       Date:  2015-03-24       Impact factor: 4.881

10.  Missing data estimation in fMRI dynamic causal modeling.

Authors:  Shaza B Zaghlool; Christopher L Wyatt
Journal:  Front Neurosci       Date:  2014-07-04       Impact factor: 4.677
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.